Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Zevra Therapeutics Inc
ZVRA
Healthcare
Zevra Therapeutics, Inc. is a rare disease company science, data, and patients need to create transformational therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical stage pipeline and commercial stage assets. Its pipeline includes arimoclomol, an orally delivered...
, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate which is being developed as a treatment for idiopathic hypersomnia (IH), a rare neurological sleep disorder, and narcolepsy. Its commercial product, AZSTARYS, a once-daily treatment for attention deficit hyperactivity disorder (ADHD), in patients aged six years and older containing its prodrug, serdexmethylphenidate (SDX), and d-methylphenidate (d-MPH). Its other commercial product is OLPRUVA.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ZVRA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(9875)
•••
Lisagerrard17
X
View Profile
View Bullboard History
Comment by
Lisagerrard17
on Jun 06, 2022 1:50pm
RE:Support?
(2)
•••
mevani
X
View Profile
View Bullboard History
Comment by
mevani
on Mar 03, 2021 12:13pm
RE:RE:RE:RE:RE:RE:RE:RE:Support?
Congrats! What a day. I have been buying the dips. I will be holding this for a bit here.
(68)
•••
Bobby90
X
View Profile
View Bullboard History
Comment by
Bobby90
on Feb 11, 2021 11:49am
RE:RE:RE:RE:RE:RE:RE:Support?
After approval with 30/13 label I can see a buyout by GPC and that could cost them $3 billion. It's not just a drug with the same potential as Vyvanse ($2.6 billion buyout). KMPH has a pipeline
...more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Feb 04, 2021 1:46pm
RE:RE:RE:RE:RE:RE:Support?
Sounds good......in the mean time..... I just take profits when they stare me in the face. Good luck to you! Cheers ps: I have no position now
(68)
•••
Bobby90
X
View Profile
View Bullboard History
Comment by
Bobby90
on Feb 04, 2021 12:37pm
RE:RE:RE:RE:RE:Support?
If GPC buys them out then we can expect a share price of $30 minimum. New River Pharmaceuticals (Vyvanse) got bought out before approval for $2.6 billion.
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Feb 04, 2021 12:14pm
RE:RE:RE:RE:Support?
Still in play.......added a small position. Cheers !
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Feb 04, 2021 12:00pm
RE:RE:RE:Support?
Has to hold hold here.......here comes the pitch
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Feb 04, 2021 11:58am
RE:RE:Support?
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Feb 04, 2021 11:49am
RE:Support?
I treat these runners like a baseball game.... so far there is 2 strikes against KMPH.....so it still can rally from here.... You don't want to be holding on the 3 rd strike. Cheers !
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 04, 2021 11:45am
Support?
I figure....... $7 has to hold or game over for the short term JMHO
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 04, 2021 11:36am
Sold KMPH......
on the $7.75 failure to break. Crystalized good profit. I will be back. Cheers
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Feb 04, 2021 11:12am
RE:My thoughts for KMPH....
I would like to add that on Jan 25th KMPH sh price double topped at ~ $7.75.... That would be a crucial pivot.... JMHO Cheers !
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 04, 2021 10:21am
My thoughts for KMPH....
We're currently trading at ~ $7.50 this a.m........... We've been here before....which was last Jan25th. I'd like to see a break of this level because I feel that we could fill the gap
...more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 04, 2021 8:33am
Movin on up.......
in this a.m's Pre-market open....just sayin! My last post was a gift IMHO.......did u BTFD ?? Just added this a.m...... in other words I am re-loading Here and will add on weakness.
...more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 28, 2021 12:07pm
Just added this a.m......
in other words I am re-loading Here and will add on weakness. Cheers !
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario